Pet Owners Turn to Unregulated Peptide Injections to Ease Dogs' Joint Pain
Dog lovers are buying cheap peptide shots, such as BPC-157 and TB-500, to treat arthritis and injuries, despite limited safety data and veterinary concerns.
Facing costly vet bills, a growing number of pet parents are experimenting with peptide injections, chiefly BPC-157 and TB-500, to alleviate joint problems and speed tissue repair in dogs. Ryan Samluk bought a month’s supply for his 11-year-old Australian-German Shepherd mix after a severe sprain, while Michael Morelli has been treating his 14-year-old pit terrier with the same “Wolverine stack” for a year. The trend gained momentum after a post by podcaster Andrew Huberman highlighted positive anecdotes from owners.
Researchers and veterinarians caution that the compounds are unapproved, lack established dosing for canines, and may stimulate blood-vessel growth that could encourage cancer. Companies such as Pawgen and startups like Loyal are watching the market, but emphasize the need for rigorous safety studies. Despite mixed results, owners continue to pursue peptides as an affordable, DIY alternative to conventional veterinary therapies.
Why it matters
Unregulated pet peptide use raises safety questions for animals and highlights gaps in veterinary oversight.
In this story
